35
51
Growth Score 35 in past quarter
-9 pts
Heat Score 51 in past quarter
-31 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
AMR Action Fund renders investment, healthcare, biotech, research and development, pharmaceutical, and antibiotic services.
Henry Skinner: Chief Executive OfficerPast Role: Novartis, Managing Director Novartis Venture Funds
Sergei Petukhov: Managing DirectorPast Role: Monet Pharmaceuticals, Vice President, Business Development
About the Company
AMR Action Fund renders investment, healthcare, biotech, research and development, pharmaceutical, and antibiotic services. They invest in firms that are developing critical pathogen therapies and lobby for market reforms to transform how society values these lifesaving drugs. They aim to help launch two to four new antimicrobials over the next
decade and build a sustainable investment environment.
Women Founded
